SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Mohilner who wrote (5544)2/3/2014 12:47:27 AM
From: Gary Mohilner   of 5665
 
cen.acs.org

This article explains why Kadcyla sales aren't rising as expected, they're currently selling at roughly their manufacturing capacity, but more capacity's coming. I started suspecting this weeks ago after seeing all sorts of drug commercials, but yet to see any for Kadcyla. Companies advertise when they have excess capacity, not when they can't meet demand. Once more capacity comes on line, I think we'll see substantially higher sales.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext